Telix Pharmaceuticals gets new technology chief
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 07 2025
0mins
Source: SeekingAlpha
Appointment of New CTO: Telix Pharmaceuticals has appointed Dr. Paul Schaffer as the Chief Technology Officer, effective immediately. Dr. Schaffer previously served as CTO at ARTMS Inc. and has extensive experience in life sciences technology.
Leadership Praise: Dr. Christian Behrenbruch, CEO of Telix, praised Dr. Schaffer's innovative contributions to isotope production and expressed enthusiasm for his addition to the Telix team as they advance in radiopharmaceutical innovation.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
